| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Common stock issued for warrants exercised | 385 | - |
| Common stock issued for options exercised | 2,695 | - |
| Net cash and cash equivalents provided by (used in) financing activities | 7,823 | -2,777 |
| Net (decrease) increase in cash and cash equivalents | -22,011 | -19,377 |
| Cash and cash equivalents at beginning of period | 49,669 | - |
| Cash and cash equivalents at end of period | 27,658 | - |
Oncology Institute, Inc. (DFPH)
Oncology Institute, Inc. (DFPH)